Orthofix Global V.P. of R&D to Present at the Texas Medical Device Symposium
LEWISVILLE, Texas--(BUSINESS WIRE)--Nov 2, 2012--Orthofix International N.V., (NASDAQ:OFIX) (the Company) announced today that the Company’s Global Vice President of Research and Development, Chuck Jaggers, will be a speaker at the first annual Texas Medical Device Symposium today at the University of Texas at Dallas. Mr. Jaggers will be addressing the historical, current, and future trends of medical device product development in orthopedics.
IEEE Engineering in Medicine and Biology Society Dallas Chapter (Dallas-EMBS) and The University of Texas at Dallas (UTD) will present the first annual Texas Medical Device Symposium, in collaboration with The University of Texas at Arlington (UTA) and The University of Texas Southwestern Medical Center (UTSW). Orthofix is a Platinum Sponsor for the event.
About Orthofix: Orthofix International N.V. is a diversified, global medical device company focused on developing and delivering innovative repair and regenerative solutions to the spine and orthopedic markets. Orthofix’s products are widely distributed around the world to orthopedic surgeons and patients via Orthofix’s sales representatives and its subsidiaries, and via collaborations with other leading orthopedic product companies. In addition, Orthofix is collaborating on R&D activities with leading research and clinical organizations such as the Musculoskeletal Transplant Foundation, the Orthopedic Research and Education Foundation, and Texas Scottish Rite Hospital for Children. For more information about Orthofix, please visit www.orthofix.com.CONTACT: Orthofix International N.V.
Mark Quick, 214-937-2924 Director of Investor Relations and Business Development firstname.lastname@example.org KEYWORD: UNITED STATES NORTH AMERICA TEXAS INDUSTRY KEYWORD: SURGERY HEALTH BIOTECHNOLOGY MEDICAL DEVICES GENERAL HEALTH SOURCE: Orthofix International N.V. Copyright Business Wire 2012 PUB: 11/02/2012 12:09 PM/DISC: 11/02/2012 12:09 PM http://www.businesswire.com/news/home/20121102005767/